Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00192829
NCT00192829
Unknown
Not Applicable

Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma

Rambam Health Care Campus2 sites in 1 country100 target enrollmentJune 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsNon-Small Cell Lung CarcinomaVenous Thromboembolism

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Non-Small Cell Lung Carcinoma
Sponsor
Rambam Health Care Campus
Enrollment
100
Locations
2
Last Updated
19 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The association between cancer and thrombosis is well known and the occurrence of thrombotic complications is commonly associated with poor prognosis. The aim os this study is to determine the possible value of hypercoagulable parameters as prognostic parameters in advanced non-small cell lung carcinoma (NSCLC).

Registry
clinicaltrials.gov
Start Date
June 2005
End Date
TBD
Last Updated
19 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Histologically or cytologically confirmed diagnosis of NSCLC.
  • •normal serum bilirubin
  • •informed concent to participate in the study

Exclusion Criteria

  • •anticoagulant therapy
  • •infectious disease

Outcomes

Primary Outcomes

Not specified

Study Sites (2)

Loading locations...

Similar Trials

Unknown
Not Applicable
Hypercoagulation Screening in CancerHealthy Blood DonorsMoli-sani SubjectsCancer Patients
NCT02622815A.O. Ospedale Papa Giovanni XXIII16,000
Recruiting
Not Applicable
A Predictive Score for Arterial Thrombosis Associated With CancerCancer
NCT05256329National and Kapodistrian University of Athens2,000
Completed
Not Applicable
A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)Treatment of Venous Thromboembolism in Cancer Patients
NCT05112666Bayer2,601
Unknown
Not Applicable
Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)Cancer
NCT00400504Rigshospitalet, Denmark500
Recruiting
Phase 1
Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and PolymorphismsCancerSolid TumorThromboembolismCardiovascular DiseasesImmune System DiseasesInflammatory DiseasesColon CancerBreast CancerProstate CancerHepatocellular CarcinomaLung CancerChemotherapyImmunotherapy
NCT06065592Lebanese University500